Pimobendan (Vetmedin) for Dogs: Uses, Dosage & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Pimobendan, sold under the brand name Vetmedin, is a prescription heart medication used in dogs. It is called an inodilator, which means it helps the heart pump more effectively while also relaxing blood vessels. That combination can reduce the workload on the heart and improve forward blood flow.

In the United States, FDA-approved pimobendan products for dogs include chewable tablets and an oral solution. It is approved to manage signs of congestive heart failure caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). As of December 19, 2025, the FDA also fully approved a pimobendan chewable product to delay the onset of congestive heart failure in dogs with Stage B2 preclinical MMVD, meaning dogs that have a murmur and heart enlargement but are not yet showing heart failure signs.

This medication is not a cure for heart disease. Instead, it is one tool your vet may use to help your dog feel better, breathe easier, and in some cases stay symptom-free longer. Dogs with heart disease often need more than one medication, so pimobendan is commonly part of a broader treatment plan rather than a stand-alone drug.

Your vet may prescribe pimobendan for dogs with clinical congestive heart failure caused by MMVD or DCM. In these dogs, the medication is used to improve heart performance and help manage signs such as coughing, exercise intolerance, fast breathing, weakness, or fluid buildup related to heart failure.

Pimobendan is also used earlier in some dogs with preclinical Stage B2 MMVD. These dogs have a heart murmur and measurable heart enlargement, but they have not yet developed congestive heart failure. In that setting, pimobendan may help delay progression to heart failure when your vet confirms the dog meets the right criteria.

It is not appropriate for every heart condition. Pimobendan should generally be avoided in diseases where making the heart contract harder could be harmful, such as hypertrophic cardiomyopathy, aortic stenosis, or other situations where increased cardiac output is not appropriate. That is why an accurate diagnosis matters before treatment starts.

Pimobendan dosing is individualized by your vet based on your dog's body weight, diagnosis, stage of heart disease, and response to treatment. A commonly referenced total daily dose for dogs is 0.4 to 0.6 mg/kg by mouth per day, usually divided into 2 doses given about 12 hours apart. Some cardiology cases may use different schedules, so follow your vet's label exactly.

For dogs with clinical congestive heart failure, the chewable tablet label describes a total daily dose of 0.5 mg/kg/day divided into 2 portions, given about 12 hours apart. Merck Veterinary Manual tables list a similar range and note that some dogs may need dosing adjustments or more frequent administration depending on the case. For Stage B2 MMVD, your vet may use the FDA-approved preclinical product and dosing directions that match that indication.

Pimobendan is often given on an empty stomach, ideally at least 1 hour before feeding, because food can reduce oral bioavailability, especially when treatment is being started. If you miss a dose, give it when you remember unless it is almost time for the next dose. Do not double up unless your vet specifically tells you to.

Because tablet sizes and liquid concentrations matter, never estimate the dose at home. Ask your vet to write out the exact milligram amount, how many tablets or milliliters to give, and whether the dose should be split evenly between morning and evening.

Many dogs tolerate pimobendan well, but side effects can happen. Reported effects include decreased appetite, diarrhea, vomiting, lethargy, and breathing changes. In dogs with heart disease, it can be hard to tell whether a new symptom is from the medication or from the heart condition getting worse, so it is important to keep your vet updated.

The product labeling and veterinary references also note that arrhythmias can occur in some dogs, and post-approval reports have included findings such as drooling, rash, hyperactivity, constipation, petechiae, hemorrhage, anemia, and rarely liver-related concerns. In dogs taking pimobendan for preclinical MMVD, commonly reported events during studies included cough, lethargy, inappetence, tachypnea, collapse, arrhythmia, and syncope, although many of those signs can also reflect disease progression rather than a direct drug effect.

See your vet immediately if your dog has collapse, fainting, severe weakness, marked restlessness, worsening breathing effort, a swollen belly, repeated vomiting, or sudden refusal to eat. Those signs may mean the heart disease is worsening, the dose needs adjustment, or another problem is happening at the same time.

If your dog accidentally gets into the bottle, call your vet or an emergency clinic right away. Flavored chewable tablets may be attractive to pets, and overdose can be dangerous.

Pimobendan is often used together with other heart medications, especially in dogs with congestive heart failure. Depending on the diagnosis, your vet may pair it with drugs such as furosemide, spironolactone, ACE inhibitors, or antiarrhythmics. Combination therapy is common in cardiology, but the exact mix depends on what type of heart disease your dog has and how advanced it is.

Some medications may blunt pimobendan's positive inotropic effect or otherwise require extra caution. Veterinary references specifically mention beta-blockers such as propranolol or atenolol and calcium channel blockers such as diltiazem or verapamil. That does not always mean the combination is forbidden, but it does mean your vet should make the decision intentionally.

Because pimobendan and its active metabolite are highly protein-bound, and because many heart patients take several medications at once, your vet should know about every prescription, supplement, probiotic, herbal product, and over-the-counter medication your dog receives. Do not start or stop another drug without checking first, especially if your dog is being managed by a veterinary cardiologist.